Schizophrenia Trial, Recruiting (NCT04237155)

Schizophrenia Trial, Recruiting NCT04237155 Sponsor: Hôpital le Vinatier Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT04237155 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Men and women between 18 and 45 years old
People who speak French as their first language
People who have normal vision, or vision that is fully corrected with glasses or contact lenses
People who have completed at least 8 years of education
People who have agreed to take part and signed a consent form
For the healthy volunteer group: people with no personal history of a diagnosed mental health condition, and no close family members (parents, siblings, or children) diagnosed with schizophrenia or bipolar disorder
For the schizophrenia patient group: people who have received a formal diagnosis of schizophrenia based on recognised diagnostic standards (DSM-5)

Who may not be able to join:

People who do not agree to take part in the study
People with a history of hearing problems
People who are unable to read
People who have a neurological condition or significant physical health condition
People who are under a legal guardianship or protective supervision arrangement (such as tutorship or curatorship)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0437915531

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04237155

Sponsor: Hôpital le Vinatier

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 0437915531

More information: https://clinicaltrials.gov/study/NCT04237155

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Men and women between 18 and 45 years old
People who speak French as their first language
People who have normal vision, or vision that is fully corrected with glasses or contact lenses
People who have completed at least 8 years of education
People who have agreed to take part and signed a consent form
For the healthy volunteer group: people with no personal history of a diagnosed mental health condition, and no close family members (parents, siblings, or children) diagnosed with schizophrenia or bipolar disorder
For the schizophrenia patient group: people who have received a formal diagnosis of schizophrenia based on recognised diagnostic standards (DSM-5)

Who may not be able to join:

People who do not agree to take part in the study
People with a history of hearing problems
People who are unable to read
People who have a neurological condition or significant physical health condition
People who are under a legal guardianship or protective supervision arrangement (such as tutorship or curatorship)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hôpital le Vinatier

Registry

ClinicalTrials.gov

Start date

7 February 2020

Est. completion

1 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Source-monitoring performances

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov